Zacks lowered shares of Novo Nordisk (NYSE:NVO) from an outperform rating to a neutral rating in a report released on Monday, AnalystRatingsNetwork.com reports. Zacks currently has $45.00 price objective on the stock. Novo Nordisk A/S (ADR) (NYSE:NVO) stock opened at $47.11 in last session, and closed at $48.23, while the day range of NVO stock is $47.00-$48.42.The stock showed a positive weekly performance of 8.59%.
The Shareholders Foundation announces that an investor who currently holds shares of Forest Laboratories, Inc. (NYSE:FRX) filed a lawsuit in effort to halt the proposed takeover of Forest Laboratories, Inc. by Actavis plc for a value of approximately $89.48 per share. Forest Laboratories, Inc. (NYSE:FRX) stock opened at $98.42, in last session and closed at $99.55, by gained 1.32%.The 52 week range was $35.22-$99.67.Company’s market capitalization is $26.97 billion.
Equities researchers at RBC Capital increased their price target on shares of Actavis plc Ordinary Shares (NYSE:ACT) from $240.00 to $249.00 in a research report issued on Friday, Analyst RN reports. The firm currently has an “outperform” rating on the stock. RBC Capital’s target price points to a potential upside of 11.98% from the company’s current price. Actavis plc Ordinary Shares (NYSE:ACT) stock gained 1.18% and finished the last session at $225.00. The EPS of the stock remained -5.27.Company’s market capitalization is $38.74 billion.
Agenus Inc (NASDAQ:AGEN) on Feb. 13 said it has completed the previously announced acquisition of 4-Antibody AG, a private European-based biopharmaceutical company. The acquisition includes the Retrocyte Display® technology platform which enables rapid discovery and optimization of fully human antibodies against a wide array of molecular targets. For the past three years, 4-Antibody has been applying Retrocyte Display to create therapeutic antibodies to six key checkpoint targets that regulate immune response to cancers and other diseases. Agenus Inc (NASDAQ:AGEN) stock opened the session at $4.19, and closed the session at $4.49.The 52 week range of the AGEN stock remained $2.40-$5.40 and the day range was $3.96-$4.60.
Leave a Reply